Optimization of Bifunctional Antisense Oligonucleotides for Regulation of Mutually Exclusive Alternative Splicing of PKM Gene.
Natalia BartyśAnna PasternakJolanta Lisowiec-WąchnickaPublished in: Molecules (Basel, Switzerland) (2022)
Oligonucleotide tools, as modulators of alternative splicing, have been extensively studied, giving a rise to new therapeutic approaches. In this article, we report detailed research on the optimization of bifunctional antisense oligonucleotides (BASOs), which are targeted towards interactions with hnRNP A1 protein. We performed a binding screening assay, Kd determination, and UV melting experiments to select sequences that can be used as a high potency binding platform for hnRNP A1. Newly designed BASOs were applied to regulate the mutually exclusive alternative splicing of the PKM gene. Our studies demonstrate that at least three repetitions of regulatory sequence are necessary to increase expression of the PKM1 isoform. On the other hand, PKM2 expression can be inhibited by a lower number of regulatory sequences. Importantly, a novel branched type of BASOs was developed, which significantly increased the efficiency of splicing modulation. Herein, we provide new insights into BASOs design and show, for the first time, the possibility to regulate mutually exclusive alternative splicing via BASOs.
Keyphrases
- case control
- binding protein
- poor prognosis
- nucleic acid
- transcription factor
- high throughput
- copy number
- genome wide identification
- high resolution
- small molecule
- dna binding
- multidrug resistant
- highly efficient
- amino acid
- long non coding rna
- cancer therapy
- gene expression
- metal organic framework
- genetic diversity
- molecularly imprinted